These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21396934)

  • 1. P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.
    Chapman JV; Gouazé-Andersson V; Karimi R; Messner MC; Cabot MC
    Exp Cell Res; 2011 Jul; 317(12):1736-45. PubMed ID: 21396934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of P-glycoprotein in HeLa cells confers resistance to ceramide cytotoxicity.
    Chapman JV; Gouazé-Andersson V; Cabot MC
    Int J Oncol; 2010 Dec; 37(6):1591-7. PubMed ID: 21042729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53.
    Morad SA; Madigan JP; Levin JC; Abdelmageed N; Karimi R; Rosenberg DW; Kester M; Shanmugavelandy SS; Cabot MC
    Biochem Pharmacol; 2013 Apr; 85(8):1057-65. PubMed ID: 23353700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells.
    Gouazé-Andersson V; Yu JY; Kreitenberg AJ; Bielawska A; Giuliano AE; Cabot MC
    Biochim Biophys Acta; 2007 Dec; 1771(12):1407-17. PubMed ID: 18035065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs.
    Shabbits JA; Mayer LD
    Mol Cancer Ther; 2002 Jan; 1(3):205-13. PubMed ID: 12467215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to the antiproliferative effect induced by a short-chain ceramide is associated with an increase of glucosylceramide synthase, P-glycoprotein, and multidrug-resistance gene-1 in cervical cancer cells.
    Gutiérrez-Iglesias G; Hurtado Y; Palma-Lara I; López-Marure R
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):809-17. PubMed ID: 25113261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells.
    Tyler A; Johansson A; Karlsson T; Gudey SK; Brännström T; Grankvist K; Behnam-Motlagh P
    Exp Cell Res; 2015 Aug; 336(1):23-32. PubMed ID: 26004871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SDZ PSC 833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein.
    Goulding CW; Giuliano AE; Cabot MC
    Cancer Lett; 2000 Feb; 149(1-2):143-51. PubMed ID: 10737718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer.
    Morad SAF; Davis TS; MacDougall MR; Tan SF; Feith DJ; Desai DH; Amin SG; Kester M; Loughran TP; Cabot MC
    Biochem Pharmacol; 2017 Apr; 130():21-33. PubMed ID: 28189725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance.
    Liu YY; Han TY; Giuliano AE; Hansen N; Cabot MC
    J Biol Chem; 2000 Mar; 275(10):7138-43. PubMed ID: 10702281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of short-chain ceramide by human cancer cells--implications for therapeutic approaches.
    Chapman JV; Gouazé-Andersson V; Messner MC; Flowers M; Karimi R; Kester M; Barth BM; Liu X; Liu YY; Giuliano AE; Cabot MC
    Biochem Pharmacol; 2010 Aug; 80(3):308-15. PubMed ID: 20385104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
    Li H; Krstin S; Wink M
    Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth.
    Flowers M; Fabriás G; Delgado A; Casas J; Abad JL; Cabot MC
    Breast Cancer Res Treat; 2012 Jun; 133(2):447-58. PubMed ID: 21935601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.
    Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
    Cancer; 1999 Jul; 86(2):300-11. PubMed ID: 10421266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KG1a cells.
    Plo I; Lehne G; Beckstrøm KJ; Maestre N; Bettaïeb A; Laurent G; Lautier D
    Mol Pharmacol; 2002 Aug; 62(2):304-12. PubMed ID: 12130682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide glycosylation potentiates cellular multidrug resistance.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    FASEB J; 2001 Mar; 15(3):719-30. PubMed ID: 11259390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells.
    Ponnapakam AP; Liu J; Bhinge KN; Drew BA; Wang TL; Antoon JW; Nguyen TT; Dupart PS; Wang Y; Zhao M; Liu YY; Foroozesh M; Beckman BS
    Bioorg Med Chem; 2014 Feb; 22(4):1412-20. PubMed ID: 24457089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy.
    Gouazé V; Yu JY; Bleicher RJ; Han TY; Liu YY; Wang H; Gottesman MM; Bitterman A; Giuliano AE; Cabot MC
    Mol Cancer Ther; 2004 May; 3(5):633-9. PubMed ID: 15141021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen retards glycosphingolipid metabolism in human cancer cells.
    Cabot MC; Giuliano AE; Volner A; Han TY
    FEBS Lett; 1996 Sep; 394(2):129-31. PubMed ID: 8843149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer.
    Ludwig JA; Szakács G; Martin SE; Chu BF; Cardarelli C; Sauna ZE; Caplen NJ; Fales HM; Ambudkar SV; Weinstein JN; Gottesman MM
    Cancer Res; 2006 May; 66(9):4808-15. PubMed ID: 16651436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.